Orphan drug landscape in the 7MM: launch patterns, market trends, and HTA insights
Orphan drugs are therapeutics developed to address rare diseases typically defined by patient population thresholds that vary across regions: fewer…
All articles by Simran Gurung
Simran Gurung
-
-
5EU Q1 2024 versus 2025: Pricing shifts, HTA outcomes, and innovative drug trends
To assess the impact of pharmaceutical policy and market dynamics on market access, GlobalData has conducted a comparative analysis of…